Back to results
US 2020/0345634 A1Published application
Compositions and Methods for Treatment of Ocular Diseases
AssigneeEyeGate Pharmaceuticals, Inc.
InventorsBrenda K. Mann, Hee-Kyoung Lee
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compositions and methods for treating ocular diseases with antibiotics. In particular, the disclosure relates to non-blurring, antibiotic-containing hydrogel compositions that have an extended contact time on the eye and do not interfere with wound healing.
Claims24
An ocular composition, comprising:
- a shear-thinning hydrogel comprising hyaluronic acid, wherein the hyaluronic acid is at a concentration of about 3 to about 10 mg/ml and is covalently crosslinked;
- and
- an antibiotic at a concentration of about 1 to about 10 mg/ml.
An ocular composition comprising:
- a shear-thinning hydrogel comprising thiolated hyaluronic acid, wherein the thiolated hyaluronic acid is at a concentration of about 3 to about 10 mg/ml and is disulfide crosslinked;
- and
- an antibiotic at a concentration of about 1 to about 10 mg/ml.
Dependencies are inferred from the claim text.